Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, tolerability, pharmacodynamics and pharmacokinetics of intravenous JNJ-39588146 versus placebo in patients with heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• JNJ-39588146

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2013-06-25